Standard BioTools Inc | Chart & Forecast SummaryKey Indicators On Trade Set Up In General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session
# Standard BioTools Inc
- Double Formation
* Forecast | Template Neckline At 2.12 | Subdivision 1
* Support=0 | Retracement & Diversity (ABC)
- Triple Formation
* 012345 | 0&1 Mark Up
Peers for comparison
−0.1768 USD
−74.90 M USD
85.33 M USD
378.68 M
Next report date
Report period
EPS estimate
Revenue estimate
Company info
Sector
Industry
CEO
Michael Egholm
Website
Headquarters
Boston
Founded
1999
IPO date
Feb 9, 2011
ISIN
US34385P1084
CUSIP
34385P108
FIGI
BBG000S8WQB6
Identifiers
ISIN US34385P1084
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
Today, LAB trades at 0.5700 USD.
For broader market analysis, dive into the technicals on the Standard BioTools Inc. stock price chart and read the latest LAB news:
– Standard BioTools Supplements Treeline Merger Proxy After Stockholder Claims
– Weekly Recap: Merger registration takes effect and Microfluidics unit sold
– Standard BioTools 3Q 2026: Revenue $19.4M, Net income $13.5M, EPS $0.03— 10-Q Summary
For broader market analysis, dive into the technicals on the Standard BioTools Inc. stock price chart and read the latest LAB news:
– Standard BioTools Supplements Treeline Merger Proxy After Stockholder Claims
– Weekly Recap: Merger registration takes effect and Microfluidics unit sold
– Standard BioTools 3Q 2026: Revenue $19.4M, Net income $13.5M, EPS $0.03— 10-Q Summary
Markets don't sleep, here's what's going on with LAB at the moment:
– Standard BioTools Supplements Treeline Merger Proxy After Stockholder Claims
– Weekly Recap: Merger registration takes effect and Microfluidics unit sold
– Standard BioTools 3Q 2026: Revenue $19.4M, Net income $13.5M, EPS $0.03— 10-Q Summary
See more updates in real-time with our News Flow.
– Standard BioTools Supplements Treeline Merger Proxy After Stockholder Claims
– Weekly Recap: Merger registration takes effect and Microfluidics unit sold
– Standard BioTools 3Q 2026: Revenue $19.4M, Net income $13.5M, EPS $0.03— 10-Q Summary
See more updates in real-time with our News Flow.
Standard BioTools Inc. is scheduled to release its next earnings report on Mar 3, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
LAB stock is 13.12% volatile and has beta coefficient of 1.38.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like LAB are typically less volatile than smaller companies
Track every detail on Standard BioTools Inc. stock chart and check out the list of the most volatile stocks — is Standard BioTools Inc. there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like LAB are typically less volatile than smaller companies
Track every detail on Standard BioTools Inc. stock chart and check out the list of the most volatile stocks — is Standard BioTools Inc. there?
To understand the LAB stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −13.14%
– 1 week — −21.51%
– 1 month — −17.99%
LAB all-time low was 0.3900 USD (Nov 17, 2026), and its highest price is 49.4553 USD (Feb 27, 2014). Find more dynamics in the Stock Heatmap and on the Standard BioTools Inc. stock chart.
– 1 day — −13.14%
– 1 week — −21.51%
– 1 month — −17.99%
LAB all-time low was 0.3900 USD (Nov 17, 2026), and its highest price is 49.4553 USD (Feb 27, 2014). Find more dynamics in the Stock Heatmap and on the Standard BioTools Inc. stock chart.
Standard BioTools Inc. market capitalization is 212.95 M, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Standard BioTools Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Standard BioTools Inc. stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Standard BioTools Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Standard BioTools Inc. stacks up against other companies
The safest way to buy Standard BioTools Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade LAB directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade LAB directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 18, 2026, the company has 389 employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Investing in Standard BioTools Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study Standard BioTools Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our LAB technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — strong sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
First, study Standard BioTools Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our LAB technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — strong sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
Standard BioTools Inc. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Standard BioTools Inc. stocks trade under the symbol LAB.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
Yes, you can track Standard BioTools Inc. financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
LAB net income for the last quarter is −16.51 M USD, while the quarter before that showed −26.76 M USD of net income which accounts for 38.31% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Standard BioTools Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Standard BioTools Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Standard BioTools Inc. does not currently pay dividends to its shareholders.
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
LAB reached its all-time high of 49.4553 USD on Feb 27, 2014. Its all-time low was 0.3900 USD and was reached on Nov 17, 2026.
Explore the Standard BioTools Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the Standard BioTools Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Standard BioTools Inc. EBITDA is −42.09 M USD, with an EBITDA margin of −101.16%.
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Standard BioTools Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Standard BioTools Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 1.35 USD and 1.35 USD for LAB, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
